Literature DB >> 26905160

Gallbladder cancer incidence in Gwalior district of India: Five-year trend based on the registry of a regional cancer center.

M A Barbhuiya, T D Singh, S S Poojary, S Gupta, M Kakkar, B R Shrivastav, P K Tiwari1.   

Abstract

BACKGROUND: We have reported here the 5-year incidence (2004-2008) of gallbladder cancer (GBC) in North Central India along with its descriptive epidemiology. This provides potential clues for better prevention. The present study has also evaluated the association of ABO blood groups with GBC. PATIENTS AND METHODS: The study comprised 742 GBC cases referred to the regional cancer hospital, Gwalior, during 2004-2008. The demographic statistics of Gwalior district was considered to calculate the relative risk and incidence rates. ABO blood group distribution amongst 90,000 healthy subjects registered in the local blood bank during 2002-2007 was taken as controls to study the association of blood groups with GBC.
RESULTS: The age-standardized total incidence rate of GBC was calculated to be 7.16/1,00,000. The relative risk of females getting GBC was 2.693 at 95% confidence interval of 2.304-3.151 (P < 0.0001). The females formed 69.5% of total cancer cases, with age-standardized incidence rate of 10/1,00,000. The mean age of male and female GBC cases was found to be 55.4 years (SD = 13, SE = 0.77) and 51.5 years (SD = 12.3, SE = 0.50), respectively. The blood groups A (P = 0.0022) and AB (P < 0.0001) had a positive association with GBC with significant level of differences in comparison to controls.
CONCLUSION: Our study provided an estimate of a 5-year incidence of GBC in North Central India for the first time. With regard to the association of risk factors like obesity, age, and urban living with GBC, the findings of the present study are contradictory to the general opinion. Blood groups A and AB were found to be associated with GBC, which would be provisional for further investigations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26905160     DOI: 10.4103/0019-509X.176736

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  7 in total

1.  Trend Analysis of Gallbladder Cancer for Dibrugarh District, Assam, During the Period of 2003-2016.

Authors:  Chandopal Saikia; Dimpal Pathak; Projnan Saikia; Utpal Dutta
Journal:  Indian J Surg Oncol       Date:  2021-09-23

2.  Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease.

Authors:  Preeti Sharma; Shushruta Bhunia; Satish S Poojary; Dinesh S Tekcham; Mustafa Ahmed Barbhuiya; Sanjiv Gupta; Braj Raj Shrivastav; Pramod Kumar Tiwari
Journal:  Tumour Biol       Date:  2016-09-14

3.  Risk factors for gallbladder cancer development in northern India: A gallstones-matched, case-control study.

Authors:  Kumudesh Mishra; Anu Behari; Pooja Shukla; Yasuo Tsuchiya; Kazuo Endoh; Takao Asai; Toshikazu Ikoma; Kazutoshi Nakamura; Vinay Kumar Kapoor
Journal:  Indian J Med Res       Date:  2021-05       Impact factor: 5.274

4.  Epigenetic regulation of APC in the molecular pathogenesis of gallbladder cancer.

Authors:  Dinesh Singh Tekcham; Satish S Poojary; Shushruta Bhunia; Mustafa Ahmed Barbhuiya; Sanjeev Gupta; Braj Raj Shrivastav; Pramod Kumar Tiwari
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

5.  Role of Cell Block Technology as an Adjunct to Fine Needle Aspiration in Evaluating as well as Differentiating Liver Lesions.

Authors:  Sujata Mallick; Mahasweta Mallik; Rabindra Nath Chatterjee; Puskar Shyam Chowdhury
Journal:  Iran J Pathol       Date:  2021-07-06

6.  Fine needle aspiration cytology of lesions of liver and gallbladder: An analysis of 400 consecutive aspirations.

Authors:  Mustafa Barbhuiya; Shushruta Bhunia; Manisha Kakkar; Braj Shrivastava; Pramod K Tiwari; Sanjiv Gupta
Journal:  J Cytol       Date:  2014-01       Impact factor: 1.000

7.  Epigenetic downregulation of desmin in gall bladder cancer reveals its potential role in disease progression.

Authors:  Shushruta Bhunia; Mustafa Ahmed Barbhuiya; Sanjiv Gupta; Braj Raj Shrivastava; Pramod Kumar Tiwari
Journal:  Indian J Med Res       Date:  2020-04       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.